Oxyphenbutazone (tandearil) in rhinoplasty. A clinical evaluation of effectiveness.
To evaluate the effectiveness of Oxyphenbutazone as an anti-inflammatory agent, a double-blind study of Oxyphenbutazone and a placebo in a group of 42 patients who had nasal cosmetic operations involving osteotomy was carried out. The observations included direct objective measurement of the width of the palpebral fissure after operation, grading of the severity of postoperative edema and ecchymosis from photographs, and observations by the patients regarding the clearing of the postoperative discoloration. It appeared from the results of these observations that Oxyphenbutazone is not effective in preventing postoperative edema in such operations or in promoting more rapid resolution of postoperative edema. It did appear to enhance the clearing of postoperative periorbital ecchymosis.
D002986:Clinical Trials as Topic; D006801:Humans; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D012225:Rhinoplasty
D010113:Oxyphenbutazone